SeaStar Medical Holding Corp
ICUNasdaqCIK 1831868HealthcareFiscal year ends Dec 31
Reports and events: 165 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-0516:20 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-032035 |
| 2026-08-1216:46 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-027353 |
| 2026-08-1216:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-027314 |
| 2026-07-0116:06 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-26-022278 |
| 2026-06-2316:14 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001437749-26-021441 |
| 2026-06-1716:07 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001437749-26-020967 |
| 2026-05-1316:45 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001437749-26-016764 |
| 2026-05-1316:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-016726 |
| 2026-05-0708:38 ET | S-1/A | Registration statement, amended | 0001213900-26-053076 |
| 2026-04-2916:10 ET | DEF 14A | Proxy statementPeriod 2026-06-17 | 0001437749-26-013871 |
| 2026-04-2816:45 ET | S-1 | Registration statement | 0001213900-26-048608 |
| 2026-04-2816:04 ET | 8-K | 8.01 Other events | 0001437749-26-013653 |
| 2026-03-2516:45 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001437749-26-009797 |
| 2026-03-2516:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-009780 |
| 2026-01-2016:03 ET | 8-K | 8.01 Other events | 0001437749-26-001541 |
| 2025-12-2316:44 ET | 8-K/A | 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-25-038701 |
| 2025-12-1816:22 ET | 8-K | 3.03 Change to security holders’ rights; 5.07 Shareholder vote results | 0001437749-25-038276 |
| 2025-11-1716:56 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-25-035449 |
| 2025-11-1416:31 ET | DEF 14A | Proxy statementPeriod 2025-12-18 | 0001213900-25-110923 |
| 2025-11-1316:53 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001437749-25-034884 |
| 2025-11-1316:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-25-034834 |
| 2025-09-2916:28 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001437749-25-030023 |
| 2025-09-2417:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-215608 |
| 2025-08-1916:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001831868-25-000014 |
| 2025-08-1409:07 ET | 8-K/A | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001831868-25-000011 |
| 2025-08-1316:45 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001831868-25-000007 |
| 2025-08-1316:15 ET | 8-K | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001831868-25-000006 |
| 2025-08-0817:02 ET | S-1 | Registration statement | 0001213900-25-073745 |
| 2025-08-0816:30 ET | 8-K | 8.01 Other events | 0000950170-25-105906 |
| 2025-08-0619:42 ET | 8-K/A | 3.01 Delisting notice | 0000950170-25-103356 |
| 2025-08-0617:57 ET | 8-K | 3.01 Delisting notice | 0000950170-25-103274 |
| 2025-08-0116:05 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-25-101408 |
| 2025-07-1616:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000950170-25-096244 |
| 2025-07-1406:24 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-063450 |
| 2025-07-0806:30 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-094442 |
| 2025-07-0216:59 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-25-093142 |
| 2025-06-2307:16 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events | 0000950170-25-088707 |
| 2025-06-2006:44 ET | S-1/A | Registration statement, amended | 0001213900-25-055807 |
| 2025-06-1608:41 ET | S-1 | Registration statement | 0001213900-25-054502 |
| 2025-06-1116:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-25-053463 |
| 2025-05-1917:01 ET | S-1 | Registration statement | 0001213900-25-045463 |
| 2025-05-1417:00 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0000950170-25-071583 |
| 2025-05-1416:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-071390 |
| 2025-05-0609:05 ET | DEF 14A | Proxy statementPeriod 2025-07-03 | 0001213900-25-040244 |
| 2025-04-2517:13 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0000950170-25-058860 |
| 2025-04-2316:05 ET | 10-K/A | Annual report, amendedPeriod 2024-12-31 | 0000950170-25-057332 |
| 2025-03-2816:23 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-046827 |
| 2025-03-2717:15 ET | 10-K | Annual reportPeriod 2024-12-31 | 0000950170-25-046200 |
| 2025-03-2716:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-25-046069 |
| 2025-03-2116:05 ET | 8-K | 5.07 Shareholder vote results | 0000950170-25-043183 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:17 ET. Listed shows no prices and gives no investment advice.